CRESCENT BIOPHARMA, INC. — All Filings
625 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
POS EX
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-4
S-4 POS
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001558370-25-000576 | Jan 31, 2025 | Jan 29, 2025 |
| 8-K | FORM 8-K | 0001104659-25-002893 | Jan 13, 2025 | — |
| DEFA14A | DEFA14A | 0001104659-25-002895 | Jan 13, 2025 | — |
| 8-K | 8-K | 0001558370-24-016472 | Dec 26, 2024 | Dec 19, 2024 |
| SC 13G | — | 0000935836-24-000745 | Nov 27, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-015537 | Nov 13, 2024 | Sep 30, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-256013 | Nov 12, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-115355 | Nov 7, 2024 | — |
| DEFA14A | DEFA14A | 0001104659-24-115361 | Nov 7, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-114867 | Nov 6, 2024 | — |
| SC 13D | GLYCOMIMETICS INC | 0000902664-24-006210 | Nov 4, 2024 | — |
| SCHEDULE 13G/A | — | 0002033801-24-000003 | Nov 4, 2024 | — |
| DEFA14A | DEFA14A | 0001104659-24-112055 | Oct 29, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-112054 | Oct 29, 2024 | Oct 28, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-201382 | Aug 15, 2024 | — |
| SCHEDULE 13G | — | 0002033801-24-000002 | Aug 14, 2024 | — |
| 4 | 4 | 0000950170-24-094800 | Aug 9, 2024 | Aug 7, 2024 |
| 10-Q | 10-Q | 0001558370-24-011579 | Aug 8, 2024 | Jun 30, 2024 |
| 4 | 4 | 0000950170-24-092864 | Aug 7, 2024 | Aug 5, 2024 |
| 4 | 4 | 0000950170-24-090910 | Aug 5, 2024 | Aug 1, 2024 |
| 4 | 4 | 0000950170-24-088020 | Jul 30, 2024 | Jul 26, 2024 |
| 8-K | 8-K | 0001558370-24-010370 | Jul 30, 2024 | Jul 24, 2024 |
| 3 | 3 | 0000950170-24-087411 | Jul 29, 2024 | Jul 25, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-187843 | Jul 29, 2024 | — |
| 8-K | 8-K | 0001558370-24-009508 | Jun 26, 2024 | Jun 21, 2024 |
| 4 | — | 0001415889-24-017978 | Jun 24, 2024 | Jun 20, 2024 |
| 4 | — | 0001415889-24-017623 | Jun 20, 2024 | Jun 18, 2024 |
| 8-K | 8-K | 0001558370-24-009140 | Jun 13, 2024 | Jun 10, 2024 |
| 8-K | 8-K | 0001558370-24-008882 | Jun 4, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-007632 | May 9, 2024 | Mar 31, 2024 |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#4E) | 0001072613-24-000441 | May 8, 2024 | — |
| 8-K | 8-K | 0001558370-24-006793 | May 6, 2024 | — |
| 8-K | 8-K | 0001558370-24-006459 | May 2, 2024 | May 1, 2024 |
| 4 | — | 0001415889-24-011862 | May 1, 2024 | — |
| 4 | — | 0001415889-24-011861 | May 1, 2024 | — |
| 4 | — | 0001415889-24-011867 | May 1, 2024 | — |
| 4 | — | 0001415889-24-011863 | May 1, 2024 | — |
| 4 | — | 0001415889-24-011869 | May 1, 2024 | — |
| 4 | — | 0001415889-24-011872 | May 1, 2024 | — |
| 4 | — | 0001415889-24-011860 | May 1, 2024 | — |
| 4 | — | 0001415889-24-009745 | Apr 2, 2024 | Mar 29, 2024 |
| 4 | — | 0001415889-24-009744 | Apr 2, 2024 | Mar 29, 2024 |
| 4 | — | 0001415889-24-009743 | Apr 2, 2024 | Mar 29, 2023 |
| DEF 14A | DEF 14A | 0001558370-24-004448 | Apr 1, 2024 | May 1, 2024 |
| ARS | ARS | 0001558370-24-004451 | Apr 1, 2024 | Dec 31, 2023 |
| 10-K | 10-K | 0001558370-24-004013 | Mar 27, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001558370-24-004015 | Mar 27, 2024 | — |
| S-8 | S-8 | 0001558370-24-004078 | Mar 27, 2024 | — |
| PRE 14A | PRE 14A | 0001558370-24-003788 | Mar 22, 2024 | May 1, 2024 |
| 8-K | 8-K | 0001558370-24-002241 | Mar 1, 2024 | — |